• Users Online: 464
  • Print this page
  • Email this page

    Article Cited by others


Rescue effects of intravitreal aflibercept in the treatment of neovascular age-related macular degeneration

Hsia Ning-Yi, Lin Chun-Ju, Lin Jane-Ming, Chen Wen-Lu, Tien Peng-Tai, Ho Yi-Hao, Kuo Chung-Yuan, Tsai Yi-Yu

Year : 2015| Volume: 5| Issue : 3 | Page no: 128-131

   This article has been cited by
1 Ziv-aflibercept for Better Regulating Neovascular Age-Related Macular Degeneration (ZEBRA): A Prospective, Randomized Trial
Haley S. DíSouza,Kapil G. Kapoor,Alan L. Wagner
Seminars in Ophthalmology. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options
Josh O. Wallsh,Ron P. Gallemore
Cells. 2021; 10(5): 1049
[Pubmed]  [Google Scholar] [DOI]
3 A Cost-Benefit Analysis of VEGF-Inhibitor Therapy for Neovascular Age-Related Macular Degeneration in the United States
Gary C. Brown,Melissa M. Brown,Sara B. Rapuano,David Boyer
American Journal of Ophthalmology. 2020;
[Pubmed]  [Google Scholar] [DOI]


Read this article